A postmarketing study of flunarizine in migraine and vertigo

Pharmacy World and Science

Volumn 19, Issue 6, 1997, Pages 269-274

  De Bock, G H ^a   Eelhart, J ^b   Van Marwijk, H W J ^a   Tromp, T P ^b   Springer, M P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b IMS Clinical Servics ^*  (Netherlands)

Author keywords

Betahistine; Depression; Flunarizine; General practitioner; Pharmacovigilance; Propranolol; Side effects

Indexed keywords

BETAHISTINE; FLUNARIZINE; PROPRANOLOL;

ADULT; ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG MONITORING; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; RISK ASSESSMENT; VERTIGO;

ADULT; DATA COLLECTION; DEPRESSIVE DISORDER; FEMALE; FLUNARIZINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NETHERLANDS; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; VASODILATOR AGENTS; VERTIGO;

EID: 0030726939     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008617825269     Document Type: Article

References (26)

1. Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Flunarizine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1984;27:6-44.
2. Verhaeghe R, Verstraete M. Drugs acting on the cerebral and peripheral circulations. In: Dukes MNG, ed. Meyler's sideeffects of drugs. Elseviers Science Publishers BV, 1992.
3. Micheli FE, Pardal MM, Giannaula R et al. Movement disorders and depression due to flunarizien and cinnarizine. Mov Disord 1989;4:139-46.
4. Benvenuti F, Baroni A, Bandinelli S, Ferrucci L, Corradetti R, Pantaleo T. Flunarizien-induced parkinsonism in the elderly. J Clin Pharmacol 1988;28:600-8.
5. Lugaresi A, Montagna P, Gallassi R, Lugaresi E. Extrapyramidal syndrome and depression induced by flunarizine. Eur Neurol 1988;28:208-11.
6. Moretti A, Lucantoni C. Flunarizine-induced parkinsonism: clinical report, Ital J Neurol Sci 1988;9:295-7.
7. Di Rosa AE, Morgante L, Meduri M et al. Parkinson-like side effects during prolonged treatment with flunarizine. Funct Neurol 1987;2:47-50.
8. Micheli F, Pardal MF, Gatto M et al. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology 1987;37:881-4.
9. Chouza C, Scaramelli A, Caamano JL, De Medina O, Aljanati R, Romero S. Parkinsonism, tardive dyskinesia, akathisia and depression induced by flunarizine. Lancet 1986;ii:1303-4.
10. Cappella D, Laporte JR, Castel JM, Tristan C, Cos A, Morales-Olivas FJ. Parkinsonism, tremor and depression induced by cinnarizine and flunarizine, Brit Med J 1988;297:722-3.
11. Assmann VCCA, Perquin WVM, Touw DJ. Extrapiramidal dyskinesia due to flunarizine. Ned Tijdschr Geneesk 1988;132:1940-2.
12. Petri H, De Vet HCW, Naus J, Urquhart J. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med 1988;7:1171-5.
13. Petri H, Leufkens H, Naus J, Silkens R, Van Hessen P, Urquhart J. Rapid method for estimating the risk of acutely controversial side effects of prescription drugs. J Clin Epidemiol 1990;43:433-9.
14. Germans restrict flunarizine use. SCRIP 1991;1599:23.
15. CPMP restricts flunarizine indications. SCRIP 1991;1601:22.
16. Verspeelt J, De Locht P, Amery WK. Post-marketing study of the use of flunarizine in vestibular vertigo and in migraine. Accepted for publication in EurJ Clin Pharm.
17. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Based on the recommendations of the Ninth Revision Conference, 1975, and adopted by the Twentyninth World Health Assembly. Geneva, World Health Organization. 1977 (Volumes 1 and 2).
18. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987 (second edition).
19. Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med 1990;150:2286-90.
20. Griffin SJ, Friedman MJ. Depressive symptoms in propranolol users. J Clin Psychiatry 1986;47:543-7.
21. Cremona-Barbaro A. Propranolol and depression [letter]. Lancet 1983;i:185.
22. Van Marwijk HWJ, Grundmeijer HGLM, Brueren MM et al. NHG-standaard depressie. Huisarts Wet 1994.
23. Breslau N, Davis GC, Schultz LR, Peterson EL. Migraine and major depression: a longitudinal study. Headache 1994;34:387-93.
24. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry 1990;47:849-53.
25. Negrotti A, Calzetti S, Sasso E. Calcium-entry blockersinduced parkinsonism: possible role of inherited suspectibility. Neurotoxicology 1992;13:261-4.
26. Laporte JR, Capella D. Useless drugs are not placebos: lessons from flunarizine and cinnarizine. Lancet 1986;853-4.